Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults

Journal of Nutrition

Volumn 141, Issue 9, 2011, Pages 1726-1730

  Semba, Richard D ^a   Arab, Lenore ^b   Sun, Kai ^a   Nicklett, Emily J ^a   Ferrucci, Luigi ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYL LYSINE; CIRCULATING ADVANCED GLYCATION END PRODUCT; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; GLYCATION; HUMAN; KIDNEY FUNCTION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; SEX; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MIDDLE AGED;

EID: 80052599568     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.143172     Document Type: Article

References (39)

1. Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65:963-75.
2. Henle T. AGEs in foods: do they play a role in uremia? Kidney Int. 2003; Suppl 84:S145-7.
3. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution.". Ann N Y Acad Sci. 2005;1043:533-44.
4. Greenwald SE. Ageing of the conduit arteries. J Pathol. 2007;211: 157-72.
5. Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens. 2009;22:74-9.
6. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis. 2008;196:9-21.
7. Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Hanssen KF, Laakso M. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia. 2007;50:1409-17.
8. Semba RD, Ferrucci L, Sun K, Beck J, Dalal M, Varadhan R, Walston J, Guralnik JM, Fried L. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women. Aging Clin Exp Res. 2009;21:182-90.
9. Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Plasma carboxymethyl-lysine, and advanced glycation end product, and allcause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc. 2009;57:1874-80.
10. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis. 2003;42:532-8.
11. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62:427-33.
12. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy of Sciences; 2000.
13. Ohgami N, Nagai R, Ikemoto M, Arai H, Miyazaki A, Hakamata H, Horiuchi S, Nakayama H. CD36 serves as a receptor for advanced glycation endproducts (AGE). J Diabetes Complications. 2002;16:56-9.
14. Kuniyasu A, Ohgami N, Hayashi S,Miyazaki A, Horiuchi S, Nakayama H. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett. 2003;537:85-90.
15. Shock NW, Greulich RC, Andres RA, Arenberg D, Casta PT, Lakatta EG, Arenberg D, Tobin JD. Normal human aging: the Baltimore Longitudinal Study of Aging.Washington, DC: U.S. Government Printing Office; 1984.
16. 2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-88.
17. Friedewald WT, Levy RI, Frederikson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
18. Boehm BO, Schilling S, Rosinger S, Lang GE, Lang GK, Kietsch-Engel R, Stahl P. Elevated serum levels of N«-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia. 2004;47:1376-9.
19. Zhang X, Frischmann M, Kientsch-Engel R, Steinmann K, Stopper H, Niwa T, Pischetsrieder M. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med. 2005;43:503-11.
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-6.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-70.
23. Paradis AM, Godin G, Pérusse L, Vohl MC. Associations between dietary patterns and obesity phenotypes. Int J Obes (Lond). 2009;33: 1419-26.
24. Powell LM, Han E, Chaloupka FJ. Economic contextual factors, food consumption, and obesity among U.S. adolescents. J Nutr. 2010;140: 1175-80.
25. Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes. 2009;4:112-8.
26. Pischetsrieder M, editor. Special issue: are dietary AGEs/ALEs a health risk? Mol Nutr Food Res. 2007;51:1069-119.
27. Ames JM. Evidence against dietary advanced glycation endproducts being a risk to human health. Mol Nutr Food Res. 2007;51:1085-90.
28. Šebeková K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects: PRO. Mol Nutr Food Res. 2007;51:1079-84.
29. Ames JM. Determination of N«-(carboxymethyl)lysine in foods and related systems. Ann N Y Acad Sci. 2008;1126:20-4.
30. Assar SH, Moloney C, Lima M, Magee R, Ames JM. Determination of N«-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids. 2009;36: 317-26.
31. Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornalley PJ. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res. 2005;49:691-9.
32. Miura J, Yamagishi SI, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. J Diabet Complications. 2003;17:16-21.
33. Mentink CJAL, Kilhovd BK, Rondas-Colbers GJWM, Torjesen PA, Wolffenbuttel BHR. Time course of specific AGEs during optimized glycaemic control in type 2 diabetes. Neth J Med. 2006;64:10-6.
34. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care. 1999;22: 1543-8.
35. Hirata K, Kubo K. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes. Endocr J. 2004;51:537-44.
36. Busch M, Franke S, Müller A, Wolf M, Gerth J, Ott U, Niwa T, Stein G. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int. 2004;66:338-47.
37. Unno Y, Sakai M, Sakamoto YI, Kuniyasu A, Nagai R, Nakayama H, Horiuchi S. Glycoaldehyde-modified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway. Ann N Y Acad Sci. 2005;1043:696-701.
38. Chesne S, Rondeau P, Armenta S, Bourdon E. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 2006;88:1467-77.
39. Singh NR, Rondeau P, Hoareau L, Bourdon E. Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin. Free Radic Res. 2007;41:1078-88.